Bioprinting in cardiovascular tissue engineering: a review
Journal Title: International Journal of Bioprinting - Year 2016, Vol 2, Issue 2
Abstract
Fabrication techniques for cardiac tissue engineering have been evolving around scaffold-based and scaffold-free approaches. Conventional fabrication approaches lack control over scalability and homogeneous cell distribution. Bioprinting provides a technological platform for controlled deposition of biomaterials, cells, and biological factors in an organized fashion. Bioprinting is capable of alternating heterogeneous cell printing, printing anatomical relevant structure and microchannels resembling vasculature network. These are essential features of an engineered cardiac tissue. Bioprinting can potentially build engineered cardiac construct that resembles native tissue across macro to nanoscale.
Authors and Affiliations
Jia Min Lee, Swee Leong Sing, Edgar Yong Sheng Tan and Wai Yee Yeong
3D printing of hydrogel composite systems: Recent advances in technology for tissue engineering
Three-dimensional (3D) printing of hydrogels is now an attractive area of research due to its capability to fabricate intricate, complex and highly customizable scaffold structures that can support cell adhesion and prom...
A novel bioactive PEEK/HA composite with controlled 3D interconnected HA network
Polyetheretherketone (PEEK) is a high-performance thermoplastic biomaterial which is currently used in a variety of biomedical orthopaedic applications. It has comparable tensile and compressive strength to cortical bone...
Osteosarcoma growth on trabecular bone mimicking structures manufactured via laser direct write
This paper describes the direct laser write of a photocurable acrylate-based PolyHIPE (High Internal Phase Emulsion) to produce scaffolds with both macro- and microporosity, and the use of these scaffolds in osteosarcoma...
Analysis of the knowledge landscape of three-dimensional bioprinting in Latin America
Bioprinting, the printing of living cells using polymeric matrixes (mainly hydrogels), has attracted great attention among science and technology circles. North America has been one of the sources of bioprinting-related...
3D printing for drug manufacturing: A perspective on the future of pharmaceuticals
Since a three-dimensional (3D) printed drug was first approved by the Food and Drug Administration in 2015, there has been a growing interest in 3D printing for drug manufacturing. There are multiple 3D printing methods...